Neo Pharma Private Limited
About Neo Pharma Private Limited
Data last updated:
Neo Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 09 March 1950 and has been in existence for over 76 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1950PTC008016. Its GSTIN is 27AAACN1812A1Z7 (Maharashtra).
The company has an authorised share capital of ₹1.09 Cr and a paid-up capital of ₹60.24 Lakh. It was formerly known as Neo Pharma Limited. It is led by directors Jayant Chaganlal Oswal and Nikunj Pravinchandra Pandya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kasturi Buildingj Tata Road, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.44 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹14.31 Cr (net margin -77.6%) and EBITDA of -₹30.09 Cr (EBITDA margin -163.2%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 34% over five years.
The company has about 43 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Neopharma. As per MCA filings, the company has open charges of ₹4,947.31 Cr and satisfied charges of ₹1,458 Cr on record. Court records list 50 cases involving the company, including 32 filed by the company and 18 filed against it; 12 cases are pending. The company has 7 deals on record (5 secondary share transfers, 1 funding round, 1 debt financing), with disclosed funding of ₹190 Cr; the latest was in March 2021. Its 3 peer companies in the Real Estate industry (Builders and Developers), with the same principal business activity (real estate activities with own or leased property) are compared by revenue, 2 larger and 1 smaller; the largest is Partum Realtors Private Limited with revenue of ₹18.46 Cr. The company has 10 MSME Form 1 returns on record between 2020 and 2024, listing 277 overdue payments to 148 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Neo Pharma has undergone 2 name changes throughout its history. The company was previously known as Neo Pharma Limited, and Neo-Pharma Private Limited. The current legal name is Neo Pharma Private Limited.
| Company Name | Status |
|---|---|
| Neo Pharma Private Limited | Current |
| Neo Pharma Limited | Previous |
| Neo-Pharma Private Limited | Previous |
Contact details
Neo Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKasturi Buildingj Tata Road, Mumbai, Maharashtra, India – 400020
- IndustryReal Estate and Construction, Real Estate Builders & Developers
To see the full contact details of Neo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Neo Pharma operates one associated brand: Neopharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Global manufacturer of pharmaceutical products, APIs, and formulations for distribution. | neopharma.com |
Business activity
The main business activities of Neo Pharma are real estate and construction. In detail, this covers real estate activities with own or leased property and buildings. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | |
| F | Construction | F1 | Buildings |
To see the full business activity and turnover split of Neo Pharma Private Limited, buy the company report.
Financials of Neo Pharma Private Limited
FY 2025 filings availableNeo Pharma Private Limited reported revenue of ₹18.44 Cr (down 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 34% over five years, including a 32% fall in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹30.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -163.2% | ||||
| Net Profit Margin | -77.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neo Pharma Private Limited, buy the company report.
Board of directors of Neo Pharma Private Limited
Neo Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayant Chaganlal Oswal | Director | 28 Mar 2015 | 11 Years 6 Months | Current |
| Nikunj Pravinchandra Pandya Also directs: Kalpataru Urbanscape LLP, Rainbow Prints Private Limited, Databank Office Staples (India) Private Limited and 5 more | Additional Director | 18 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Neo Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Real Estate industry (Builders and Developers), with the same principal business activity (real estate activities with own or leased property), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Partum Realtors Private Limited | ₹18.46 Cr (FY 2024) | 19535.0% | Mumbai, Maharashtra, India | |||
| Saransh Realtors India Private Limited | ₹18.44 Cr (FY 2025) | 12.0% | Gurgaon, Haryana, India | |||
| Neo Pharma Private Limitedthis company | ₹18.44 Cr (FY 2025) | -₹14.31 Cr | -77.6% | -32.0% | 43 | Mumbai, Maharashtra, India |
| Matoshree Infrastructure Private Limited | ₹18.41 Cr (FY 2020) | -24.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Neo Pharma Private Limited, buy the company report.
Auditor
Neo Pharma Private Limited is audited by Singhi & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Singhi & Co | FY 2023 | 302049E |
Shareholding
The shareholding of Neo Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neo Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2024 | 101003869 | Others | ₹55 Cr | Open | |
| 30 Apr 2021 | 100446535 | Hdfc Bank Limited | ₹4,572.31 Cr | Open | |
| 23 Oct 2019 | 100302194 | Others | ₹95 Cr | Open | |
| 14 Feb 2018 | 100161956 | Others | ₹225 Cr | Open | |
| 22 Apr 2022 | 100567580 | Others | ₹100 Cr | Satisfied |
To see the full charge records of Neo Pharma Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Neo Pharma Private Limited has 7 deals on record (5 secondary share transfers, 1 funding round, 1 debt financing), with disclosed funding of ₹190 Cr; the latest was in March 2021.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Debt financing | ₹175 Cr | Investors: Ask Property Investment Advisors |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Yugdharm Investment and Trading Company Private Limited |
| Mar 2012 | Secondary share transfer | Undisclosed | Seller: HDFC Asset Management Company Limited |
| Nov 2007 | Secondary share transfer | Undisclosed | Buyer: Sharadchandrika Munot Family Trust, 2 individuals Seller: Mofatraj P. Munot As Trustee Of Sunita Trust, 3 individuals |
| Nov 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
To see the full deal history of Neo Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Neo Pharma Private Limited has 50 court cases on record: 32 filed by Neo Pharma, 18 filed against it. 12 cases are pending and 38 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 36 | 12 | 8 |
| District courts | 11 | 5 | 4 |
| Supreme Court | 2 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 50)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed against the company by Kumar Urban Development Pvt. Ltd. | Pending |
| District court, Mumbai Small Causes Court, Maharashtra | Appeal | Filed by the company against Messrs Kasturi and Sons Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Ms Antrix Financial Engineers Pvt Ltd | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against individuals | Pending |
To see the full case history of Neo Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Neo Pharma Private Limited has 10 MSME Form 1 returns on record between 2020 and 2024, listing 277 overdue payments to 148 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 148)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dial4loanz Credit Services Private Limited | |||
| Everlast Composites LLP | |||
| an individual supplier | |||
| Insta Mark Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Neo Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Neo Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Employees & EPFO
Neo Pharma Private Limited has a workforce of 43 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Neo Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN1812A1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Neo Pharma Private Limited, buy the company report.
Recent activity
Neo Pharma Private Limited has 11 board changes on record since 2011: 3 appointments and 8 cessations. The latest: Nikunj Pravinchandra Pandya was appointed as Additional Director on 18 Apr 2025.
34 earlier events are in the company report.
News
Frequently asked questions
Neo Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 09 March 1950 (76+ years old) and is registered under CIN U24239MH1950PTC008016.
Neo Pharma has 2 current directors:
- Jayant Chaganlal Oswal - Director
- Nikunj Pravinchandra Pandya - Additional Director
The latest financial statements of Neo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Neo Pharma is 27AAACN1812A1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Neo Pharma is U24239MH1950PTC008016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neo Pharma has 50 court cases on record: 32 filed by the company and 18 filed against it. 12 are pending. Most are in the high courts.
Neo Pharma was incorporated on 09 March 1950, making it 76+ years old. It is registered with the Registrar of Companies, Mumbai.
Neo Pharma has 7 deals on record (5 secondary share transfers, 1 funding round, 1 debt financing), with disclosed funding of ₹190 Cr; the latest was in March 2021.
The peers of Neo Pharma by revenue are Partum Realtors Private Limited, Saransh Realtors India Private Limited, Matoshree Infrastructure Private Limited, all in the Real Estate industry (Builders and Developers), with the same principal business activity (real estate activities with own or leased property).
Nikunj Pravinchandra Pandya was appointed as Additional Director on 18 Apr 2025. Bajrang Lal Bararia ceased to be Additional Director on 31 Dec 2021. Venkatesh Gajanan Bhandare ceased to be Additional Director on 29 Sep 2018. Neo Pharma has 11 board changes on record in total.
Neo Pharma has 10 MSME Form 1 returns on record between 2020 and 2024, listing 277 overdue payments to 148 micro and small suppliers. The latest return was filed on 30 Apr 2024.
The registered office of Neo Pharma is at Kasturi Buildingj Tata Road, Mumbai, Maharashtra, India – 400020.